Healthcare
Enveric Biosciences Reports Positive Preclinical Results for Lead Drug Candidate EB-003
Company Strengthens IP Portfolio and Prepares for EB-003 IND Submission
Eli Lilly Strikes $2.75 Billion AI Drug Discovery Deal With InSilico
The partnership aims to leverage InSilico's AI-powered drug development capabilities to create new treatments across multiple therapeutic areas.
Oryzon Genomics Granted U.S. Patent for Iadademstat Combinations with Venetoclax
Key combination for the treatment of first-line acute myeloid leukemia (AML)
- Young Latter-day Saints in Massachusetts Strengthen Faith and Community
- Takeda Announces Massive Layoffs, Cutting Over 600 US Jobs
- Insilico Medicine and Lilly Announce Landmark AI-Powered Drug Discovery Collaboration
- NANOBIOTIX Presents First Data from Randomized Lung Cancer Trial
- Enveric Biosciences Reports Positive Preclinical Results for Lead Drug Candidate EB-003
- Eli Lilly Strikes $2.75 Billion AI Drug Discovery Deal With InSilico
